Loading…
Based on limited metadata, this Warning Letter issued to Hangzhou Badi Daily Use Chemical Company on August 29, 2019, concerns drug products manufactured or distributed by the company. While the specific violations cannot be detailed without access to the full letter text, the FDA's issuance indicates non-compliance with applicable drug regulations. The letter falls under FDA's drug product oversight authority, though the specific issuing field office is not identified in the available metadata.